Your browser doesn't support javascript.
loading
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.
Fendler, Wolfgang P; Weber, Manuel; Iravani, Amir; Hofman, Michael S; Calais, Jérémie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Small, Eric J; Smith, Matthew R; Perez, Paola M; Hope, Thomas A; Rauscher, Isabel; Londhe, Anil; Lopez-Gitlitz, Angela; Cheng, Shinta; Maurer, Tobias; Herrmann, Ken; Eiber, Matthias; Hadaschik, Boris.
Afiliação
  • Fendler WP; University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany. wolfgang.fendler@uk-essen.de.
  • Weber M; University of California Los Angeles, Los Angeles, California.
  • Iravani A; University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
  • Hofman MS; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Calais J; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Czernin J; University of California Los Angeles, Los Angeles, California.
  • Ilhan H; University of California Los Angeles, Los Angeles, California.
  • Saad F; Ludwig-Maximilian-University, Munich, Germany.
  • Small EJ; Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Québec, Canada.
  • Smith MR; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Perez PM; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.
  • Hope TA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Rauscher I; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Londhe A; Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Lopez-Gitlitz A; Janssen Research & Development, Titusville, New Jersey.
  • Cheng S; Janssen Research & Development, Los Angeles, California.
  • Maurer T; Janssen Research & Development, Raritan, New Jersey.
  • Herrmann K; Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
  • Eiber M; University of Hamburg-Eppendorf, Hamburg, Germany.
  • Hadaschik B; University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Clin Cancer Res ; 25(24): 7448-7454, 2019 12 15.
Article em En | MEDLINE | ID: mdl-31511295
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Glutamato Carboxipeptidase II / Neoplasias de Próstata Resistentes à Castração / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Antagonistas de Androgênios / Recidiva Local de Neoplasia / Antígenos de Superfície Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Glutamato Carboxipeptidase II / Neoplasias de Próstata Resistentes à Castração / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Antagonistas de Androgênios / Recidiva Local de Neoplasia / Antígenos de Superfície Idioma: En Ano de publicação: 2019 Tipo de documento: Article